JP2021522244A5 - - Google Patents
Info
- Publication number
- JP2021522244A5 JP2021522244A5 JP2020559423A JP2020559423A JP2021522244A5 JP 2021522244 A5 JP2021522244 A5 JP 2021522244A5 JP 2020559423 A JP2020559423 A JP 2020559423A JP 2020559423 A JP2020559423 A JP 2020559423A JP 2021522244 A5 JP2021522244 A5 JP 2021522244A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl group
- hydrogen atom
- atom
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1853709 | 2018-04-27 | ||
| FR1853709A FR3080620B1 (fr) | 2018-04-27 | 2018-04-27 | Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices |
| PCT/FR2019/050982 WO2019207257A1 (fr) | 2018-04-27 | 2019-04-26 | Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522244A JP2021522244A (ja) | 2021-08-30 |
| JP2021522244A5 true JP2021522244A5 (enExample) | 2022-05-02 |
| JP7408894B2 JP7408894B2 (ja) | 2024-01-09 |
Family
ID=63036097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559423A Active JP7408894B2 (ja) | 2018-04-27 | 2019-04-26 | チューブリン重合阻害活性及び免疫調節特性を有する化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11634405B2 (enExample) |
| EP (1) | EP3784662B1 (enExample) |
| JP (1) | JP7408894B2 (enExample) |
| AU (1) | AU2019259112B2 (enExample) |
| CA (1) | CA3097622A1 (enExample) |
| DK (1) | DK3784662T3 (enExample) |
| ES (1) | ES2932370T3 (enExample) |
| FR (1) | FR3080620B1 (enExample) |
| WO (1) | WO2019207257A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116143693B (zh) * | 2020-06-24 | 2026-04-10 | 中国药科大学 | 一种具有抗肿瘤活性的2-甲基喹啉类衍生物及其合成方法和用途 |
| CN115417860B (zh) * | 2020-08-03 | 2023-10-20 | 中国药科大学 | 一种具有抗肿瘤活性的喹唑啉类衍生物及其合成方法和用途 |
| CN113173915B (zh) * | 2021-03-29 | 2022-12-09 | 中南大学湘雅医院 | 抗皮肤肿瘤化合物及其应用 |
| CN113620874B (zh) * | 2021-08-10 | 2024-02-06 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2-三氟甲基-4-氨基-喹啉衍生物及其用途 |
| CN114436975B (zh) * | 2022-01-26 | 2023-10-31 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2-三氟甲基-4-氨基喹唑啉类化合物及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9323290D0 (en) * | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
| GB9514265D0 (en) * | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
| PT1154774E (pt) * | 1999-02-10 | 2005-10-31 | Astrazeneca Ab | Derivados de quinazolina como inibidores de angiogenese |
| BR0111377A (pt) * | 2000-06-06 | 2003-06-03 | Pfizer Prod Inc | Derivados de tiofeno úteis como agentes anticancerìgenos |
| GB0126433D0 (en) * | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
| AU2004289303A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Fused heterocyclic compounds |
| AU2004309166B2 (en) * | 2003-12-23 | 2008-02-21 | Pfizer Inc. | Novel quinoline derivatives |
| WO2006074187A2 (en) * | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Method of treating brain cancer |
| GB0508717D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Chemical compounds |
| JP2009508917A (ja) * | 2005-09-20 | 2009-03-05 | アストラゼネカ アクチボラグ | 抗癌剤としてのキナゾリン誘導体 |
| FR2914640B1 (fr) | 2007-04-04 | 2012-11-16 | Centre Nat Rech Scient | Iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de polymerisation de la tubuline |
-
2018
- 2018-04-27 FR FR1853709A patent/FR3080620B1/fr active Active
-
2019
- 2019-04-26 US US17/050,772 patent/US11634405B2/en active Active
- 2019-04-26 ES ES19733845T patent/ES2932370T3/es active Active
- 2019-04-26 DK DK19733845.2T patent/DK3784662T3/da active
- 2019-04-26 AU AU2019259112A patent/AU2019259112B2/en active Active
- 2019-04-26 EP EP19733845.2A patent/EP3784662B1/fr active Active
- 2019-04-26 JP JP2020559423A patent/JP7408894B2/ja active Active
- 2019-04-26 CA CA3097622A patent/CA3097622A1/fr active Pending
- 2019-04-26 WO PCT/FR2019/050982 patent/WO2019207257A1/fr not_active Ceased
-
2023
- 2023-03-06 US US18/117,847 patent/US12371417B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522244A5 (enExample) | ||
| JP2022534426A5 (enExample) | ||
| JP2024100974A5 (enExample) | ||
| JP2022551185A5 (enExample) | ||
| JP2022141773A5 (enExample) | ||
| JP2021522262A5 (enExample) | ||
| JP2016518437A5 (enExample) | ||
| JP2009536221A5 (enExample) | ||
| RU2005141127A (ru) | Композиции для лечения инфекции крупного рогатого скота и свиней | |
| JP2017508733A5 (enExample) | ||
| JPWO2023106310A5 (enExample) | ||
| JP2006508903A5 (enExample) | ||
| JP2010539166A5 (enExample) | ||
| JP2008510691A5 (enExample) | ||
| JP2014513704A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2023535453A5 (enExample) | ||
| JP2015501820A5 (enExample) | ||
| JP2023531709A5 (enExample) | ||
| JP2019529419A5 (enExample) | ||
| MX380516B (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico | |
| JP2006507355A5 (enExample) | ||
| JP2023535815A5 (enExample) | ||
| JP2017531677A5 (enExample) | ||
| JP2023537271A5 (enExample) |